Development and Effectiveness of a Mobile app-Based Myofunctional Therapy Program for Improving Obstructive Sleep Apnea

Pusan National University0 个研究点目标入组 26 人开始时间: 待定最近更新: 2024年7月23日

适应症

试验速览

暂无简介。

•Inclusion Criteria
•Individuals who understand the purpose of this study and agree to participate.
•Individuals diagnosed with obstructive sleep apnea by a sleep specialist based on the results of a sleep study, and who have been recommended myofunctional therapy by the sleep specialist.
•Adults aged 18 years or older.
•Individuals with no communication disabilities.
•Individuals who can attach the sleep study device to at least one finger and wrist.
•Individuals who have a mobile phone capable of running the mobile app (Android or iOS) and can use it without assistance.

•Exclusion Criteria
•Individuals with severe nasal obstruction or facial deformities confirmed by imaging studies.
•Individuals whom the sleep specialist determines to be unable to perform myofunctional therapy due to musculoskeletal disorders.
•Individuals with autonomic nervous system dysfunction, peripheral neuropathy, vascular disease, heart disease, or lung disease.
•Individuals taking medications that may affect peripheral arterial tone (adrenergic blockers).
•Types of adrenergic blockers: Tolazoline, Trazodone, Phenoxybenzamine, Phentolamine, Doxazosin, Silodosin, Alfuzosin, Tamsulosin, Terazosin, Prazosin, Mirtazapine, Atipamezole, Yohimbine, Idazoxan, Labetalol, Carvedilol.
•(Note: Criteria 3 and 4 are exclusion criteria to prevent errors that may occur when using portable sleep study devices.)

发起方